Thus, to verify the microarray results and to evaluate the significance of the findings, SPARCL1 was chosen to examine the expression level by real-time quantitative PCR and Western blot in a larger cohort of 4 pairs of gastric GIST samples. This evidence concerns the gene SPARCL1 and gastrointestinal stromal tumor.